Global G-Protein Coupled Receptor (GPCR) Targeting Sales Market Report 2018

This report studies the global G-Protein Coupled Receptor (GPCR) Targeting market status and forecast, categorizes the global G-Protein Coupled Receptor (GPCR) Targeting market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/528415/global-g-protein-coupled-receptor-gpcr-targeting-sales-market

In the next five years, the GACR of GPCR Tools is about 3.6%, and the revenue in the 2022 is about 1760 M USD. GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 40% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein.

The classification of GPCR Tools includes GPCR Consumables and GPCR Equipment, and the proportion of GPCR Consumables in 2016 is about 70% and the proportion is increasing trend from 2012 to 2016.

In terms of therapeutic areas, the market has been segmented into: Oncology, cardiovascular system, central nervous system (CNS), etc. Oncology was the largest segment of the global GPCRs market in 2016 and the proportion in 2016 is 50%.

North America is the largest consumption place, with a consumption market share nearly 49% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30.4%.

Market competition is intense. Thermo Fisher Scientific, PerkinElmer, Merck, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry.

The global G-Protein Coupled Receptor (GPCR) Targeting market is valued at 79 million US$ in 2017 and will reach 100 million US$ by the end of 2025, growing at a CAGR of 2.6% during 2018-2025.

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/528415/global-g-protein-coupled-receptor-gpcr-targeting-sales-market

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA - 91748
USA: +1 626 295 2442
Email – inquiry@qyrsearch.com
Web – www.qyresearch.com

This release was published on openPR.